Ezra M. Friedberg, Director at Pelthos Therapeutics Inc. (PTHS), sold 558 shares at $26.03 ($15K) on 2026-07-02, disclosed to the SEC on 2026-07-07.
Scheduled sale ($15k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.03 | 534 | $14K | 95.5% |
| 2 | $27.33 | 24 | $656 | 4.5% |
| Total | $26.09 avg | 558 | $15K | 100% |
| Filing → |
| PTHS | SELL | 2025-11-26 | $280K | — | Filing → |
| CHRO | BUY | 2024-03-12 | $100K | — | Filing → |